Study finds evidence of resistance to COVID-19 drugs

by

Resistance to Paxlovid is already evident among viral SARS-CoV-2 variants currently circulating globally, indicating that this stand-alone drug known as a protease inhibitor could soon become less effective in treating COVID-19 infections.

Leave A Comment

Your email address will not be published. Required fields are marked *